Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

PENNSYLVANIA: OraSure Founders Reunite for New Project


Morning Call (Allentown, PA) (07.18.2013)

Two founders of Bethlehem, Pa.-based OraSure Technologies, maker of the OraQuick HIV test, will work together to create a TB test. In 1988, Sam Niedbala and Mike Gausling partnered with two other friends to form what would become OraSure. Niedbala's new company, TB Biosciences, recently announced it received $1.5 million from a group of investors led by Originate Ventures, the venture capital fund co-founded by Gausling. TB Biosciences is working on a means of diagnosing the disease using antibodies found in the blood of patients with active TB. Niedbala believes that developing an improved TB test is part of the larger fight against HIV because so many HIV-positive individuals actually died of TB. According to TB Biosciences, preliminary trials indicated a 90-percent accuracy rate for the company’s technology, which the New York University (NYU) School of Medicine has developed throughout the past two decades. "This would be a major breakthrough in tuberculosis testing and could go a long way to saving many lives each year," said Frank Rimalovski, executive director of the NYU Innovation Venture Fund.


Copyright © 2013 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in July 23, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.